CI Platform
Sign in
HCmed Innovations Co., Ltd.6934TAI
Current ReportFundamental Reports

Asia / TAIWAN

Report Sections1

Available for this company

Reporting UnitBillions

TAI

Company Overview

HCmed Innovations Co Ltd. provides platforms for inhalation therapy using mesh technology. Its products include Pulmogine and AdheResp. The company offers comprehensive aerosol characterization analytical services to support the development and optimization of inhalation products. HCmed Innovations was founded by Chieh Sheng Cheng, Wen Yue Tsai, Shaogi Huang and Tsung Hung Hsieh on October 06, 2014 and is headquartered in Taipei, Taiwan.

HCmed Innovations Co Ltd. provides platforms for inhalation therapy using mesh technology. Its products include Pulmogine and AdheResp. The company offers comprehensive aerosol characterization analytical services to support the development and optimization of inhalation products. HCmed Innovations was founded by Chieh Sheng Cheng, Wen Yue Tsai, Shaogi Huang and Tsung Hung Hsieh on October 06, 2014 and is headquartered in Taipei, Taiwan.

Includes quarterly earnings and dividends.

Company Details

Major IndustryPharmaceuticals & Biotechnology
Sub IndustryBiological Products Exc. Diagnostic
CountryTAIWAN
Employees61
Reporting UnitBillions
Primary ExchangeTAI
Instrument TypeEquity
Wright IDC158G2YVW

Key Metrics

Current price$82.40
Market cap$2.98 B
P/E ration/a
Common shares36.1 M
Share typeGu
Quality ratingLCD5
Dividend yield0.00%

Recent stock performance

1 Week-0.2%
4 Week+11.5%
13 Week+12.9%

Officers

n/a

Address

TAIWAN

Phonen/a

Quarterly Earnings & Dividends

Quarterly earnings and dividend history is not available for this company.

Try another report for annual statements, Wright Quality history or comparative analysis.